International Journal of Endocrinology and Metabolism
Research Institute for Endocrine Sciences
Authors
Dyslipidemia is associated with cardiovascular morbidities and mortality. Currently, fasting lipid profile determination is used to monitor treatment response. Recently, postprandial lipemia is of increasing interest because of its atherogenic and thrombogenic potential and also was found to be more predictive for cardiovascular diseases.
To demonstrate postprandial lipemia among patients with cardiovascular diseases despite low fat diet, normal fasting lipid profile and even statin regimen.
Patients aged 40-80 years old with cardiovascular diseases (i.e. coronary artery disease and cerebrovascular disease) more than 6 months, on statin treatment for more than 6 months and normal fasting lipid profile (according to NCEP ATP III guidelines) were included. Study exclusion criteria were pregnancy, acute cardiovascular events < 6 months, hepatic or renal failure. Finally, twelve patients were included.
The triglyceride level showed a significant rise from fasting to 2 hours after breakfast with a mean difference of 23.86 mg/dL (P =0.012). The level peaked at 4 hours after breakfast with a mean difference (MD) of 72.02 mg/dL (P =0.002). Subsequent triglyceride levels plateaued and were significantly higher than the baseline (P <0.05) until the 12th hour of observation. VLDL levels showed a similar pattern. Levels increased significantly from fasting to 2h after breakfast (mean difference: 4.49 mg/dL, P = 0.007), then plateaued and further increased 4 hours after breakfast (MD: 14.01 mg/dL, P = 0.002). VLDL levels were significantly higher than fasting (P < 0.05) and did not return to baseline until the 12th hour of observation. In contrast, the levels of total cholesterol, HDL and LDL decreased postprandially.
Triglyceride and VLDL peaking and plateauing were observed in patients with cardiovascular diseases despite low fat diet, normal fasting lipid profile and statin regimen. These findings may raise more attentions in monitoring and management of dyslipidemia in patients with cardiovascular and cerebrovascular events.
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Salesi M, rashidi H, Fatahi F. Effect of smoking on postprandial hypertriglyceridemia. Zahedan J Res Med Sci. 2010;12(1):e94347. doi:
Talal N, Alidrisi HA, Mansour AA. Comparison Between Measuring of Lipid Profile in Fasting and Non-Fasting States: A Cross-Sectional Study from Iraq. Shiraz E-Med J. 2020;21(5):e94544. doi: https://doi.org/10.5812/semj.94544
Gabriel FS, Samson CE, Abejuela ZR, Sicat-Gabriel PR, Sumpio JP, et al. Postprandial Effect of Orlistat on the Peaking of Lipid Level After Sequential High Fat Meals. Int J Endocrinol Metab. 2012;10(2):. doi: https://doi.org/10.5812/ijem.2920
Fazlinezhad A, Ghaffarzadegan K, Shakeri MT, Taghavi S, Ziallhagh R, et al. Lipoprotein (a) level in acute myocardial infarction: comparison with healthy subjects. Shiraz E-Med J. 2005;6(1 and 2):31833. doi:
Rahmanian K, Shojaei M, Hooshmand F, Sharifi N, Rahmanian V. Association Between Circulating Oxidized LDL Cholesterol Levels and Premature Myocardial Infarction: A Case-Control Study. Health Scope. 2024;13(4):e141349. doi: https://doi.org/10.5812/healthscope-141349
Last Update: 2 weeks ago
Last Update: 2 weeks ago
Last Update: 2 weeks ago
Last Update: 2 hours ago
Last Update: 9 hours ago
Last Update: 5 days ago
